Novartis Bioventures Ltd sold $459K of Ra Pharmaceuticals, Inc.

10% owner

Sold$459,437

$23.38Price

19,647Shares

−1%Stake

What RARX did after the filing

Prices for RARX after this filing aren't in yet.

Traded Fri, Jun 2. Filed Tue, Jun 6, 12:27 PM ET, during the session. Not investment advice.